These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 26432274

  • 1. The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement.
    Helft G.
    Arch Cardiovasc Dis; 2015 Oct; 108(10):469-71. PubMed ID: 26432274
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Should all stent patients have prolonged dual antiplatelet therapy?
    Kirtane AJ, King SB.
    JACC Cardiovasc Interv; 2015 May; 8(6):873-875. PubMed ID: 25999115
    [No Abstract] [Full Text] [Related]

  • 4. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW, Kang SH, Park JJ, Yang HM, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS.
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [Abstract] [Full Text] [Related]

  • 5. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
    Cassese S, De Luca G, Villari B, Berti S, Bellone P, Alfieri A, Montinaro A, Quaranta G, Marraccini P, Piscione F, MATRIX Study Investigators.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):408-16. PubMed ID: 21735531
    [Abstract] [Full Text] [Related]

  • 6. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, Räber L, Applegate R, Waxman S, Gordon P, Kaneshige K, Leon MB, DESERT Investigators.
    JACC Cardiovasc Interv; 2014 Oct 01; 7(10):1093-102. PubMed ID: 25240540
    [Abstract] [Full Text] [Related]

  • 7. Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous?
    Casella G, Resciniti E, Gallo P.
    J Cardiovasc Med (Hagerstown); 2018 Feb 01; 19 Suppl 1():e21-e25. PubMed ID: 29045308
    [No Abstract] [Full Text] [Related]

  • 8. Foreword.
    Curr Probl Cardiol; 2017 Dec 01; 42(12):402. PubMed ID: 29032851
    [No Abstract] [Full Text] [Related]

  • 9. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G, PRODIGY Investigators.
    JACC Cardiovasc Interv; 2014 Jan 01; 7(1):20-8. PubMed ID: 24332420
    [Abstract] [Full Text] [Related]

  • 10. Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery.
    Bozzani A, Ferlini M, Rossini R, Musumeci G, Arici V, Bramucci E, Setacci C.
    J Cardiovasc Surg (Torino); 2015 Aug 01; 56(4):681-3. PubMed ID: 25008060
    [No Abstract] [Full Text] [Related]

  • 11. Duration of Dual Anti-Platelet Therapy Post-Percutaneous Intervention: Is There A Correct Amount of Time?
    Garratt KN.
    Prog Cardiovasc Dis; 2015 Aug 01; 58(3):285-98. PubMed ID: 26343876
    [Abstract] [Full Text] [Related]

  • 12. Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.
    Verdoia M, Schaffer A, Barbieri L, Montalescot G, Collet JP, Colombo A, Suryapranata H, De Luca G.
    Angiology; 2016 Mar 01; 67(3):224-38. PubMed ID: 26069031
    [Abstract] [Full Text] [Related]

  • 13. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
    Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):395-405. PubMed ID: 22109961
    [Abstract] [Full Text] [Related]

  • 14. Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.
    Manchuelle A, Delhaye C, Schurtz G, Sudre A, Hurt C, Bonello L, Puymirat E, Bauters C, Lemesle G.
    Arch Cardiovasc Dis; 2015 Apr 01; 108(4):235-43. PubMed ID: 25682548
    [Abstract] [Full Text] [Related]

  • 15. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, Yang S, Ge Z, Shan SJ, Li XB, Xu T, Kan J, Lin L, Han YL.
    Cardiovasc Ther; 2013 Aug 01; 31(4):193-200. PubMed ID: 22954234
    [Abstract] [Full Text] [Related]

  • 16. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
    Buszman PP, Orlik B, Trela B, Milewski K, Kozlowski M, Pruski M, Drzewiecki J, Peppas A, Granada JF, Kaluza GL, Buszman PE.
    Catheter Cardiovasc Interv; 2013 Sep 01; 82(3):E155-62. PubMed ID: 23109067
    [Abstract] [Full Text] [Related]

  • 17. Stent thrombosis: a clinical perspective.
    Claessen BE, Henriques JP, Jaffer FA, Mehran R, Piek JJ, Dangas GD.
    JACC Cardiovasc Interv; 2014 Oct 01; 7(10):1081-92. PubMed ID: 25341705
    [Abstract] [Full Text] [Related]

  • 18. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.
    Helft G.
    Arch Cardiovasc Dis; 2013 May 01; 106(5):271-3. PubMed ID: 23769401
    [No Abstract] [Full Text] [Related]

  • 19. Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice.
    Cho MS, Park DW.
    Korean J Intern Med; 2017 Sep 01; 32(5):769-779. PubMed ID: 28823143
    [Abstract] [Full Text] [Related]

  • 20. Dual antiplatelet therapy after drug-eluting stents: defining the proper duration.
    Park SJ, Kang SM, Park DW.
    Coron Artery Dis; 2014 Jan 01; 25(1):83-9. PubMed ID: 24322887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.